BDNF plasma levels decrease during benzodiazepine withdrawal in patients suffering from comorbidity of depressive disorder and benzodiazepine dependence

被引:14
作者
Heberlein, Annemarie [1 ,2 ]
Lenz, Bernd [2 ]
Muschler, Marc [1 ,2 ]
Frieling, Helge [1 ,2 ]
Buechl, Rebecca [2 ]
Groeschl, Michael [3 ]
Kornhuber, Johannes [2 ]
Bleich, Stefan [1 ,2 ]
Hillemacher, Thomas [1 ,2 ]
机构
[1] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Addict Res Ctr, D-30625 Hannover, Germany
[2] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany
[3] Univ Hosp Erlangen, Dept Pediat, Erlangen, Germany
关键词
BDNF; GDNF; Benzodiazepine dependence; Benzodiazepine withdrawal; Depression; Comorbidity; MOOD DISORDERS; BRAIN; VOLUME;
D O I
10.1007/s00213-010-1781-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alterations in the expression of neurotrophic growth factors like brain-derived neuronal factor (BDNF) and glial cell line-derived neuronal growth factor (GDNF) have been frequently associated with affective disorders. Indeed, benzodiazepine dependence is typically combined with affective disorders. Aim of the study was to investigate plasma levels of the neuronal growth factors BDNF and GDNF during benzodiazepine withdrawal in patients suffering from comorbidity of benzodiazepine dependence and depressive disorder. In total, 11 patients were included in the study. Seven patients completed benzodiazepine withdrawal. We found that BDNF plasma levels were significantly increased in the benzodiazepine-dependent patients (p = 0.011) compared to a healthy control group (14 age- and sex-matched persons) and decreased significantly (p = 0.029) due to benzodiazepine withdrawal, whereas GDNF plasma levels did not differ (p = 0.886) and change (p = 0.180) significantly. In conclusion, we assume that benzodiazepines may partly act by similar neurobiological mechanisms like antidepressant medication, which may explain the high frequency of benzodiazepine dependence in affective disorders.
引用
收藏
页码:213 / 215
页数:3
相关论文
共 8 条
[1]   Neurotrophins and depression [J].
Altar, CA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (02) :59-61
[2]   An update on regional brain volume differences associated with mood disorders [J].
Campbell, S ;
MacQueen, G .
CURRENT OPINION IN PSYCHIATRY, 2006, 19 (01) :25-33
[3]   Lower hippocampal volume in patients suffering from depression: A meta-analysis [J].
Campbell, S ;
Marriott, M ;
Nahmias, C ;
MacQueen, GM .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (04) :598-607
[4]   Diazepam delays the death of hippocampal CA1 neurons following global ischemia [J].
Corbett, Dale ;
Larsen, Jennifer ;
Langdon, Kristopher D. .
EXPERIMENTAL NEUROLOGY, 2008, 214 (02) :309-314
[5]   Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder:: A comparative post-mortem study [J].
Michel, Tanja M. ;
Frangou, Sophia ;
Camara, Sibylle ;
Thlemeyer, Dorothea ;
Jecel, Julia ;
Tatschner, Thomas ;
Zoechling, Robert ;
Gruenblatt, Edna .
EUROPEAN PSYCHIATRY, 2008, 23 (06) :413-420
[6]  
Michelini S, 1996, PHARMACOPSYCHIATRY, V29, P127
[7]   Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis [J].
Qashu, Felicia ;
Figueiredo, Taiza H. ;
Aroniadou-Anderjaska, Vassiliki ;
Apland, James P. ;
Braga, Maria F. M. .
AMINO ACIDS, 2010, 38 (01) :189-197
[8]   Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants [J].
Shimizu, E ;
Hashimoto, K ;
Okamura, N ;
Koike, K ;
Komatsu, N ;
Kumakiri, C ;
Nakazato, M ;
Watanabe, H ;
Shinoda, N ;
Okada, S ;
Iyo, M .
BIOLOGICAL PSYCHIATRY, 2003, 54 (01) :70-75